GlassScriptPhysician profile
Ramez Nader Abdalla
NPI 1407410392
$10,155.36
in general payments reported to CMS, 2019-2025
8 companies · $701 in 2025
The $701 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,507 · 2021: $2,909 · 2022: $2,167 · 2023: $324 · 2024: $1,547 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,796 · Travel and Lodging: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,795.53 |
| Travel and Lodging | $776.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,071.41 | 2020-2025 | Penumbra System, Penumbra Coil 400 |
| Stryker Corporation | $3,049.55 | 2021-2025 | Spinejack, Optablate, Target |
| Medical Device Business Services, INC. | $1,952.17 | 2022 | |
| Medtronic, INC. | $1,628.83 | 2021-2025 | Solitaire X, Pipeline, Axium Primetm |
| Microvention, INC. | $383.40 | 2024-2025 | Web Aneurysm Embolization System, Sofia 6f-131cm Str, Tubing Kit - Stroke |
| Asahi Intecc USA, INC. | $24.06 | 2025 | Asahi Neurology Wires |
| Cardinal Health 200 LLC | $23.29 | 2021 | |
| Terumo Medical Corporation | $22.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramez Abdalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.